Table 1.
Clinical characteristics of the AF and control subjects.
| Characteristics | AF (n = 75) | Controls (n = 94) | p-value |
| Age (years) | 71.63±8.62(63-82) | 71.25±8.17(60-85) | 0.7708 |
| Gender (% male) | 62.67 | 64.89 | 0.7646 |
| SBP (mm Hg) | 145.33±24.86 | 143.21±23.75 | 0.5713 |
| DBP (mm Hg) | 81.76±10.37 | 83.31±11.44 | 0.3632 |
| BMI (kg/m2) | 23.54±3.37 | 23.86±3.78 | 0.5671 |
| LVEF (%) | 59.86±6.21 | 61.27±6.59 | 0.1536 |
| Left atrial dimension (mm) | 48.16±7.13 | 37.42±6.82 | 0.0000 |
| TC (mmol/L) | 4.86±0.59 | 4.72±0.51 | 0.1001 |
| LDL-C (mmol/L) | 2.50±0.41 | 2.54±0.46 | 0.5566 |
| HDL-C (mmol/L) | 1.41±0.25 | 1.47±0.29 | 0.1576 |
| TG (mmol/L) | 1.60±0.52 | 1.53±0.48 | 0.3654 |
| Diabetes mellitus (%) | 21.33 | 24.47 | 0.6308 |
| Smoking (%) | 17.33 | 11.70 | 0.2974 |
| Diuretics (%) | 38.67 | 28.72 | 0.1724 |
| Calcium antagonist (%) | 48.00 | 48.94 | 0.9037 |
| β-blockers (%) | 34.67 | 26.60 | 0.2561 |
| ACE inhibitors (%) | 50.67 | 54.26 | 0.6425 |
| ARB (%) | 29.33 | 32.98 | 0.6118 |
AF, atrial fibrillation; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; LVEF, left ventricular ejection fraction; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.